CD8A and neoplasm: For example, by transducing DCs with membrane-bound IL-12, engineered DCs significantly improved the stimulation of CD8+ T cells and the polarization of Th1 cells in the tumor microenvironment, resulting in a minimal concentration of IL-12 in the bloodstream82.